The rollout of Russia s Sputnik vaccine was roundly criticised, now more than a billion doses have been ordered around the world
FriFriday 12
updated
FriFriday 12
In August 2020, Russia became the first country to approve a COVID-19 vaccine.
(
Share
Print text only
Cancel
When Russia registered a vaccine for COVID-19, it was widely ridiculed and even declared dangerous but new research is revealing it could be highly effective.
Key points:
A medical journal reports Russia s Sputnik vaccine has an efficacy rate of over 91 per cent
Felix Light says he found it easy to get vaccinated in Moscow
The Oxford/AstraZeneca vaccine is close to 100 per cent effective against the most severe illness from COVID-19, says epidemiologist
Global coronavirus infections may start to decrease in March with vaccinations and other active epidemic control measures being carried out, prominent respiratory disease expert Zhong Nanshan said on Sunday.
Fujitsu delivers cashless, contactless retail experience for masked shoppers Jan. 25 06:00 am JST Jan. 25 | 06:33 am JST KAWASAKI
Fujitsu Laboratories Ltd has announced the development of a new multi-factor biometric authentication technology to deliver an innovative shopping experience, combining non-contact biometrics that filter the verification target through facial data with identification performed via palm vein recognition. This technology enables identification with greater than 99% accuracy even when the user wears a mask, and will be showcased at a concept cashless Lawson convenience store at the Fujitsu Technology Square office in Shin-Kawasaki for a field trial.
Multi-factor biometric authentication terminal in use
Users wearing masks present challenges to conventional facial recognition filtering technologies because a large part of the face is obscured, rendering authentication impossible in some cases. With the newly developed technology, howe
Fujitsu Delivers Cashless, Contactless Retail Experience for Masked Shoppers with Hygienic, Multi-Factor Biometric Authentication Technology
KAWASAKI, Japan, Jan 21, 2021 - (JCN Newswire) - Fujitsu Laboratories, Ltd. has announced the development of a new multi-factor biometric authentication technology to deliver an innovative shopping experience for the New Normal era, combining non-contact biometrics that filter the verification target through facial data with identification performed via palm vein recognition. This technology enables identification with greater than 99% accuracy even when the user wears a mask, and will be showcased at a concept cashless Lawson convenience store at the Fujitsu Technology Square office in Shin-Kawasaki, Japan (1), for a field trial starting from January 2021.
OTTAWA While critics of Canada’s vaccine rollout continue to point to the more accelerated COVID-19 vaccine rollout in the United States, Dr. Anthony Fauci says he isn’t planning on American life getting back to some semblance of normality any earlier than Canadian officials are aiming for. In an exclusive interview with Evan Solomon on CTV’s Question Period, the director of the United States’ National Institute of Allergy and Infectious Diseases said that on the current timeline for immunizations in that country, he isn’t expecting life to start looking as it did pre-COVID-19 until the fall or winter of 2021.